Which statement about pituitary adenomas is true?

Which statement about pituitary adenomas is true?

• A. Nonprolactin-secreting macroadenomas require neurosurgical evaluation
• B. Prolactin-secreting macroadenomas respond without surgery
• C. Microadenomas always require neurosurgery
• D. Prolactin levels do not guide therapy

Answer: (A)

When managing pituitary adenomas, the key is to match treatment to tumor size and function. Macroadenomas (larger tumors) can press on surrounding structures such as the optic nerves, causing vision problems, and their size makes medical shrinkage less reliable if the tumor isn’t prolactin-secreting. Nonprolactin-secreting macroadenomas often require neurosurgical evaluation for removal to relieve mass effect and prevent further compression. This is why the statement about needing neurosurgical input for nonprolactin-secreting macroadenomas is true. In contrast, prolactin-secreting tumors—especially smaller ones—are usually treated first with dopamine agonists, which lower prolactin levels and often shrink the tumor, sometimes avoiding surgery. Microadenomas, regardless of whether they produce prolactin, are not automatically surgical cases; many are managed medically or observed depending on symptoms and hormonal activity. Prolactin levels are routinely used to guide therapy and monitor response. So the true point is that nonprolactin-secreting macroadenomas commonly require neurosurgical evaluation due to mass effect and limited medical options to shrink them, whereas prolactin-secreting tumors are typically managed medically first, with surgery reserved for specific cases.

When managing pituitary adenomas, the key is to match treatment to tumor size and function. Macroadenomas (larger tumors) can press on surrounding structures such as the optic nerves, causing vision problems, and their size makes medical shrinkage less reliable if the tumor isn’t prolactin-secreting. Nonprolactin-secreting macroadenomas often require neurosurgical evaluation for removal to relieve mass effect and prevent further compression. This is why the statement about needing neurosurgical input for nonprolactin-secreting macroadenomas is true.

In contrast, prolactin-secreting tumors—especially smaller ones—are usually treated first with dopamine agonists, which lower prolactin levels and often shrink the tumor, sometimes avoiding surgery. Microadenomas, regardless of whether they produce prolactin, are not automatically surgical cases; many are managed medically or observed depending on symptoms and hormonal activity. Prolactin levels are routinely used to guide therapy and monitor response.

So the true point is that nonprolactin-secreting macroadenomas commonly require neurosurgical evaluation due to mass effect and limited medical options to shrink them, whereas prolactin-secreting tumors are typically managed medically first, with surgery reserved for specific cases.